 Sarah Jolley
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 11 | 2025 | 871 | 3.100 |
Why?
| | Alcoholism | 6 | 2025 | 823 | 1.510 |
Why?
| | Psychotic Disorders | 5 | 2021 | 179 | 1.440 |
Why?
| | Critical Illness | 8 | 2024 | 837 | 1.420 |
Why?
| | Occupational Therapy | 2 | 2022 | 99 | 1.040 |
Why?
| | Early Ambulation | 2 | 2017 | 25 | 0.950 |
Why?
| | Pneumonia | 4 | 2023 | 656 | 0.940 |
Why?
| | Survivors | 4 | 2025 | 504 | 0.900 |
Why?
| | Patient Admission | 1 | 2025 | 203 | 0.810 |
Why?
| | Physical Therapy Modalities | 3 | 2017 | 319 | 0.790 |
Why?
| | Child Behavior | 2 | 2015 | 251 | 0.770 |
Why?
| | Respiration, Artificial | 3 | 2017 | 685 | 0.720 |
Why?
| | Problem Behavior | 1 | 2023 | 104 | 0.720 |
Why?
| | Mobility Limitation | 2 | 2019 | 63 | 0.710 |
Why?
| | Adolescent Health Services | 1 | 2021 | 76 | 0.670 |
Why?
| | Psychomotor Agitation | 1 | 2020 | 72 | 0.640 |
Why?
| | Adolescent Behavior | 2 | 2015 | 538 | 0.630 |
Why?
| | Aftercare | 2 | 2023 | 218 | 0.590 |
Why?
| | Substance-Related Disorders | 2 | 2025 | 1102 | 0.570 |
Why?
| | Patient Discharge | 3 | 2024 | 933 | 0.560 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 136 | 0.540 |
Why?
| | Opioid-Related Disorders | 2 | 2023 | 564 | 0.530 |
Why?
| | Betacoronavirus | 1 | 2020 | 276 | 0.530 |
Why?
| | Adult | 26 | 2025 | 39391 | 0.500 |
Why?
| | Fluid Therapy | 1 | 2017 | 142 | 0.500 |
Why?
| | Mental Health Services | 1 | 2021 | 447 | 0.490 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 337 | 0.470 |
Why?
| | Life Support Care | 1 | 2016 | 39 | 0.470 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 96 | 0.460 |
Why?
| | Marijuana Use | 1 | 2019 | 221 | 0.460 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 374 | 0.450 |
Why?
| | Coronavirus Infections | 1 | 2020 | 371 | 0.450 |
Why?
| | Bullying | 1 | 2015 | 44 | 0.450 |
Why?
| | Humans | 50 | 2025 | 141754 | 0.450 |
Why?
| | Hospitals, Teaching | 1 | 2015 | 115 | 0.440 |
Why?
| | HIV Infections | 3 | 2019 | 3022 | 0.430 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2023 | 345 | 0.430 |
Why?
| | Middle Aged | 20 | 2025 | 34647 | 0.420 |
Why?
| | Adolescent Development | 1 | 2015 | 90 | 0.420 |
Why?
| | Neuromuscular Diseases | 1 | 2016 | 142 | 0.420 |
Why?
| | Self Concept | 1 | 2015 | 262 | 0.410 |
Why?
| | Crime Victims | 1 | 2015 | 130 | 0.400 |
Why?
| | Clinical Protocols | 1 | 2015 | 273 | 0.400 |
Why?
| | Family Therapy | 1 | 2013 | 66 | 0.390 |
Why?
| | Alcohol Drinking | 2 | 2019 | 835 | 0.390 |
Why?
| | Activities of Daily Living | 3 | 2023 | 427 | 0.390 |
Why?
| | Female | 28 | 2025 | 75943 | 0.370 |
Why?
| | Retrospective Studies | 15 | 2025 | 16374 | 0.370 |
Why?
| | Male | 26 | 2025 | 70179 | 0.360 |
Why?
| | Hospitalization | 8 | 2025 | 2264 | 0.350 |
Why?
| | Louisiana | 2 | 2024 | 26 | 0.340 |
Why?
| | Prevalence | 5 | 2025 | 2799 | 0.340 |
Why?
| | Cognition | 3 | 2023 | 1228 | 0.320 |
Why?
| | Motor Activity | 1 | 2015 | 720 | 0.320 |
Why?
| | Aged | 12 | 2025 | 24746 | 0.320 |
Why?
| | Child Development | 1 | 2015 | 499 | 0.310 |
Why?
| | Cohort Studies | 9 | 2025 | 5815 | 0.310 |
Why?
| | Referral and Consultation | 1 | 2014 | 799 | 0.280 |
Why?
| | Length of Stay | 3 | 2020 | 1263 | 0.280 |
Why?
| | Multicenter Studies as Topic | 3 | 2023 | 363 | 0.270 |
Why?
| | Weight Gain | 1 | 2011 | 539 | 0.260 |
Why?
| | Ethanol | 2 | 2022 | 629 | 0.260 |
Why?
| | Adolescent | 11 | 2025 | 22130 | 0.250 |
Why?
| | Attitude of Health Personnel | 1 | 2014 | 1183 | 0.250 |
Why?
| | Prospective Studies | 8 | 2025 | 7777 | 0.240 |
Why?
| | United States | 7 | 2025 | 15310 | 0.240 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 325 | 0.230 |
Why?
| | Colorado | 3 | 2025 | 4629 | 0.220 |
Why?
| | Washington | 2 | 2015 | 160 | 0.210 |
Why?
| | Hospital Mortality | 2 | 2025 | 924 | 0.200 |
Why?
| | Hand Strength | 1 | 2024 | 132 | 0.200 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1498 | 0.200 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5697 | 0.190 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2938 | 0.190 |
Why?
| | Body Mass Index | 1 | 2011 | 2385 | 0.190 |
Why?
| | Telerehabilitation | 1 | 2022 | 40 | 0.180 |
Why?
| | Critical Care | 3 | 2024 | 650 | 0.180 |
Why?
| | Quality of Life | 4 | 2023 | 3014 | 0.180 |
Why?
| | Child | 5 | 2023 | 22414 | 0.170 |
Why?
| | Naltrexone | 1 | 2022 | 102 | 0.170 |
Why?
| | Central Nervous System Depressants | 1 | 2021 | 89 | 0.170 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2903 | 0.170 |
Why?
| | Risk Factors | 4 | 2024 | 10482 | 0.170 |
Why?
| | Nursing Assessment | 1 | 2020 | 57 | 0.160 |
Why?
| | School Health Services | 1 | 2023 | 233 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 243 | 0.160 |
Why?
| | Schools | 1 | 2023 | 453 | 0.150 |
Why?
| | Mobile Applications | 1 | 2022 | 185 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 881 | 0.150 |
Why?
| | Exercise | 1 | 2011 | 2112 | 0.150 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2021 | 185 | 0.150 |
Why?
| | Frailty | 1 | 2022 | 177 | 0.150 |
Why?
| | Tobacco Smoking | 1 | 2018 | 25 | 0.150 |
Why?
| | Pandemics | 3 | 2023 | 1656 | 0.140 |
Why?
| | Tobacco Use | 1 | 2018 | 65 | 0.140 |
Why?
| | Decision Making | 1 | 2025 | 961 | 0.140 |
Why?
| | Emotions | 1 | 2023 | 579 | 0.130 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 122 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 512 | 0.130 |
Why?
| | Tobacco Products | 1 | 2018 | 98 | 0.130 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 99 | 0.130 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2019 | 285 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 126 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 650 | 0.130 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2019 | 205 | 0.130 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 176 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1634 | 0.130 |
Why?
| | Linear Models | 1 | 2019 | 858 | 0.130 |
Why?
| | Muscular Diseases | 1 | 2017 | 113 | 0.120 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 42 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 1039 | 0.120 |
Why?
| | Alcohol-Related Disorders | 1 | 2017 | 125 | 0.120 |
Why?
| | Health Facility Size | 1 | 2015 | 11 | 0.110 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 23 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 820 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 962 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 708 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 861 | 0.110 |
Why?
| | Homosexuality, Male | 1 | 2016 | 209 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 44 | 0.110 |
Why?
| | Internal-External Control | 1 | 2015 | 77 | 0.110 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2019 | 364 | 0.110 |
Why?
| | Comorbidity | 1 | 2019 | 1664 | 0.100 |
Why?
| | Aggression | 1 | 2015 | 200 | 0.100 |
Why?
| | Physical Therapists | 1 | 2014 | 61 | 0.100 |
Why?
| | Logistic Models | 2 | 2017 | 2092 | 0.100 |
Why?
| | Pilot Projects | 2 | 2022 | 1826 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2063 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 894 | 0.100 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.090 |
Why?
| | Schizophrenic Psychology | 1 | 2012 | 98 | 0.090 |
Why?
| | Nurses | 1 | 2014 | 184 | 0.090 |
Why?
| | Young Adult | 4 | 2025 | 13749 | 0.090 |
Why?
| | Data Collection | 1 | 2014 | 662 | 0.090 |
Why?
| | Psychometrics | 1 | 2015 | 739 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2018 | 1132 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2014 | 5974 | 0.080 |
Why?
| | Attitude to Health | 1 | 2012 | 458 | 0.070 |
Why?
| | Schizophrenia | 1 | 2012 | 454 | 0.070 |
Why?
| | Energy Intake | 1 | 2011 | 513 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2193 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1757 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 6966 | 0.060 |
Why?
| | Child, Preschool | 1 | 2021 | 11512 | 0.060 |
Why?
| | Physicians | 1 | 2014 | 942 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3508 | 0.060 |
Why?
| | Viral Load | 1 | 2025 | 506 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 124 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 339 | 0.040 |
Why?
| | New Orleans | 1 | 2018 | 15 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2024 | 412 | 0.040 |
Why?
| | Needs Assessment | 1 | 2021 | 385 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2013 | 11181 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2019 | 128 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 1027 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 792 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 397 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1547 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 381 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2022 | 587 | 0.030 |
Why?
| | Tidal Volume | 1 | 2017 | 102 | 0.030 |
Why?
| | Sputum | 1 | 2019 | 313 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 859 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3597 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1250 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1474 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2025 | 1406 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 556 | 0.030 |
Why?
| | Selectins | 1 | 2016 | 8 | 0.030 |
Why?
| | Angiopoietin-1 | 1 | 2016 | 11 | 0.030 |
Why?
| | Angiopoietin-2 | 1 | 2016 | 15 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 92 | 0.030 |
Why?
| | Urban Population | 1 | 2018 | 485 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1090 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2800 | 0.030 |
Why?
| | Mental Health | 1 | 2022 | 759 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1472 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1254 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 241 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2902 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1990 | 68 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 561 | 0.020 |
Why?
| | Neurofibromatosis 1 | 1 | 1990 | 56 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1321 | 0.020 |
Why?
| | Genetic Markers | 1 | 1990 | 343 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4137 | 0.020 |
Why?
| | DNA | 1 | 1990 | 1444 | 0.010 |
Why?
| | Animals | 1 | 2017 | 37749 | 0.010 |
Why?
| | Genetic Carrier Screening | 1 | 1990 | 30 | 0.010 |
Why?
| | Lod Score | 1 | 1990 | 64 | 0.010 |
Why?
| | DNA Probes | 1 | 1990 | 59 | 0.010 |
Why?
| | Genetic Linkage | 1 | 1990 | 288 | 0.000 |
Why?
| | Pedigree | 1 | 1990 | 511 | 0.000 |
Why?
| | Alleles | 1 | 1990 | 891 | 0.000 |
Why?
|
|
Jolley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|